PortfoliosLab logo
ADMA vs. AMSC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADMA and AMSC is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ADMA vs. AMSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

ADMA:

1.79

AMSC:

0.85

Sortino Ratio

ADMA:

2.66

AMSC:

1.73

Omega Ratio

ADMA:

1.34

AMSC:

1.19

Calmar Ratio

ADMA:

3.84

AMSC:

0.72

Martin Ratio

ADMA:

7.91

AMSC:

2.30

Ulcer Index

ADMA:

15.40%

AMSC:

30.80%

Daily Std Dev

ADMA:

67.27%

AMSC:

91.67%

Max Drawdown

ADMA:

-91.28%

AMSC:

-99.57%

Current Drawdown

ADMA:

-17.63%

AMSC:

-96.42%

Fundamentals

Market Cap

ADMA:

$4.82B

AMSC:

$947.82M

EPS

ADMA:

$0.84

AMSC:

$0.09

PE Ratio

ADMA:

24.04

AMSC:

266.89

PEG Ratio

ADMA:

0.00

AMSC:

-0.06

PS Ratio

ADMA:

10.49

AMSC:

4.78

PB Ratio

ADMA:

12.59

AMSC:

4.92

Total Revenue (TTM)

ADMA:

$459.38M

AMSC:

$156.16M

Gross Profit (TTM)

ADMA:

$241.40M

AMSC:

$44.16M

EBITDA (TTM)

ADMA:

$158.29M

AMSC:

$8.69M

Returns By Period

In the year-to-date period, ADMA achieves a 17.73% return, which is significantly higher than AMSC's 0.53% return. Over the past 10 years, ADMA has underperformed AMSC with an annualized return of 9.09%, while AMSC has yielded a comparatively higher 14.63% annualized return.


ADMA

YTD

17.73%

1M

-5.26%

6M

3.33%

1Y

119.22%

3Y*

114.70%

5Y*

48.88%

10Y*

9.09%

AMSC

YTD

0.53%

1M

34.49%

6M

-19.01%

1Y

76.73%

3Y*

68.13%

5Y*

32.08%

10Y*

14.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ADMA Biologics, Inc.

Risk-Adjusted Performance

ADMA vs. AMSC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
The Risk-Adjusted Performance Rank of ADMA is 9494
Overall Rank
The Sharpe Ratio Rank of ADMA is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of ADMA is 9393
Sortino Ratio Rank
The Omega Ratio Rank of ADMA is 9191
Omega Ratio Rank
The Calmar Ratio Rank of ADMA is 9898
Calmar Ratio Rank
The Martin Ratio Rank of ADMA is 9292
Martin Ratio Rank

AMSC
The Risk-Adjusted Performance Rank of AMSC is 7878
Overall Rank
The Sharpe Ratio Rank of AMSC is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of AMSC is 8181
Sortino Ratio Rank
The Omega Ratio Rank of AMSC is 7575
Omega Ratio Rank
The Calmar Ratio Rank of AMSC is 7878
Calmar Ratio Rank
The Martin Ratio Rank of AMSC is 7575
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ADMA vs. AMSC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ADMA Sharpe Ratio is 1.79, which is higher than the AMSC Sharpe Ratio of 0.85. The chart below compares the historical Sharpe Ratios of ADMA and AMSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

ADMA vs. AMSC - Dividend Comparison

Neither ADMA nor AMSC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADMA vs. AMSC - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum AMSC drawdown of -99.57%. Use the drawdown chart below to compare losses from any high point for ADMA and AMSC. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ADMA vs. AMSC - Volatility Comparison

ADMA Biologics, Inc. (ADMA) has a higher volatility of 22.65% compared to American Superconductor Corporation (AMSC) at 13.51%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than AMSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

ADMA vs. AMSC - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and American Superconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00M20212022202320242025
114.80M
61.40M
(ADMA) Total Revenue
(AMSC) Total Revenue
Values in USD except per share items

ADMA vs. AMSC - Profitability Comparison

The chart below illustrates the profitability comparison between ADMA Biologics, Inc. and American Superconductor Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-80.0%-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%20212022202320242025
53.2%
26.6%
(ADMA) Gross Margin
(AMSC) Gross Margin
ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a gross profit of 61.10M and revenue of 114.80M. Therefore, the gross margin over that period was 53.2%.

AMSC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported a gross profit of 16.33M and revenue of 61.40M. Therefore, the gross margin over that period was 26.6%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported an operating income of 34.88M and revenue of 114.80M, resulting in an operating margin of 30.4%.

AMSC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported an operating income of 1.32M and revenue of 61.40M, resulting in an operating margin of 2.1%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a net income of 26.90M and revenue of 114.80M, resulting in a net margin of 23.4%.

AMSC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported a net income of 2.47M and revenue of 61.40M, resulting in a net margin of 4.0%.